Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?

被引：0
|
作者：
Erica O. Miller
Ronald G. Schwartz
机构：
[1] University of Rochester Medical Center,Cardiology Division, Department of Medicine
[2] University of Rochester Medical Center,Nuclear Medicine Division, Department of Imaging Sciences
来源：
Journal of Nuclear Cardiology | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：119 / 121
页数：2
相关论文
共 50 条
  • [41] Cardiovascular risk in patients with end-stage renal disease: A potential role for advanced glycation end products
    Wang, YJ
    Marshall, SM
    Thompson, MG
    Hoenich, NA
    CARDIOVASCULAR DISORDERS IN HEMODIALYSIS, 2005, 149 : 168 - 174
  • [42] The assessment of coronary artery disease in patients with end-stage renal disease
    Poli, Federica E.
    Gulsin, Gaurav S.
    McCann, Gerry P.
    Burton, James O.
    Graham-Brown, Matthew P.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (05) : 721 - 734
  • [43] Assessment of inflammation and nutrition in patients with end-stage renal disease
    Don, BR
    Kaysen, GA
    JOURNAL OF NEPHROLOGY, 2000, 13 (04) : 249 - 259
  • [44] ASSESSMENT OF INFECTION RISK IN VITILIGO PATIENTS UNDERGOING DIALYSIS FOR END-STAGE RENAL DISEASE
    Shah, Pearl V.
    Waller, Jennifer
    Tran, Sarah
    Baer, Stephanie
    Taskar, Varsha
    Bollag, Wendy
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (06)
  • [45] Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients
    Buraczynska, Monika
    Ksiazek, Piotr
    Zukowski, Pawel
    Benedyk-Lorens, Ewa
    Orlowska-Kowalik, Grazyna
    CLINICAL IMMUNOLOGY, 2009, 132 (02) : 285 - 290
  • [46] Risk of Band Keratopathy in Patients with End-Stage Renal Disease
    Shih-Feng Weng
    Ren-Long Jan
    Chun Chang
    Jhi-Joung Wang
    Shih-Bin Su
    Chien-Cheng Huang
    Sung-Huei Tseng
    Yuh-Shin Chang
    Scientific Reports, 6
  • [47] Risk of Band Keratopathy in Patients with End-Stage Renal Disease
    Weng, Shih-Feng
    Jan, Ren-Long
    Chang, Chun
    Wang, Jhi-Joung
    Su, Shih-Bin
    Huang, Chien-Cheng
    Tseng, Sung-Huei
    Chang, Yuh-Shin
    SCIENTIFIC REPORTS, 2016, 6
  • [48] CHLAMYDIA PNEUMONIAE AND CARDIOVASCULAR DISEASE IN END-STAGE RENAL DISEASE PATIENTS: AN UPDATE
    Rassu, M.
    Filardo, S.
    Mastromarino, P.
    EUROPEAN JOURNAL OF INFLAMMATION, 2013, 11 (02) : 359 - 365
  • [49] The evaluation of underlyin cardiovascular disease among patients with end-stage renal disease
    Hedayati, SS
    Szczech, LA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 246 - 253
  • [50] Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : 67 - 72
12345